谷歌浏览器插件

订阅小程序

在清言上使用

立即登录

学术主页个人账号

我的关注论文收藏浏览历史

Bimekizumab Maintained Efficacy Responses Through 52 Weeks in Biologic Disease-Modifying Antirheumatic Drugnaïve Patients with Psoriatic Arthritis Who Were Responders at Week 16: Results from BE OPTIMAL, a Phase 3, Activereference Study

William R. Tillett,Joseph F. Merola,Yoshiya Tanaka,Ennio G. Favalli,Dennis Mcgonagle,Jessica A. Walsh,Diamant Thaci,Barbara Ink,Rajan Bajracharya,Vanessa Taieb,Christopher T. Ritchlin

RHEUMATOLOGY（2024）

引用 0|浏览29

暂无评分

关键词

Psoriatic arthritis,Clinical trials

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要